tirzepatide as compared with semaglutide for the treatment of obesity vs and liraglutide weight loss in patients overweight or without diabetes: A short-term cost-effectiveness analysis in United States Tirzepatide vs. Semaglutide: Which Weight

Invest 122 , 21762194 (2012)

Clinical effect depends on the reason for use, individual metabolism, formulation, and adherence, so a clinician sets the cadence after reviewing your history and goals rather than following a blanket interval from an article

This summary provides basic information about Zepbound but does not include all information known about this medicine

In a statement dated 8 March 2023, Helen Knight, director of medicines evaluation at NICE, said: Our committee has made specific recommendations to ensure it remains value for money for the taxpayer, and it can only be used for a maximum of two years. Commenting on the guidance, Hannah Beba, consultant diabetes pharmacist for NHS Leeds Clinical Commissioning Group, said she had some reservations around the often relapsing nature of obesity and the provision of only a two-year access to the medication

Sources :

Because of the lack of reliable routine methods to determine -cell mass in humans, indirect testing of -cell function could be a suitable alternative